Given that previous studies have implicated NF-kB signaling in LSC maintenance [8, 9] and that emetine has anti-AML potential [23], we hypothesized that emetine could eradicate AML stem/progenitor cells. The gene discussed is NFKB1; the disease is acute myeloid leukemia.